Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
9.39
-0.17 (-1.78%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Assembly Biosciences Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Assembly Biosciences stock have an average target of 33, with a low estimate of 31 and a high estimate of 35. The average target predicts an increase of 251.44% from the current stock price of 9.39.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $31 $33 $35 $35
Change +230.14% +251.44% +272.74% +272.74%

Analyst Ratings

The average analyst rating for Assembly Biosciences stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 111112
Buy 000000
Hold 111111
Sell 000000
Strong Sell 000000
Total 222223

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Guggenheim
Guggenheim
Strong Buy
Initiates
$31
Strong Buy Initiates $31 +230.14% Mar 25, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Mar 24, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Dec 27, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Sep 24, 2024
Jefferies
Jefferies
Strong Buy
Upgrades
$2$35
Strong Buy Upgrades $2$35 +272.74% Sep 20, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
31.61M
from 28.52M
Increased by 10.82%
Revenue Next Year
24.86M
from 31.61M
Decreased by -21.33%
EPS This Year
-6.42
from -6.69
EPS Next Year
-9.23
from -6.42
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
79.11M6.25M-7.16M28.52M31.61M24.86M60.56M
Revenue Growth
395.55%-92.09%--298.16%10.82%-21.33%143.58%
EPS
-21.05-36.00-23.08-13.38-6.69-6.42-9.23-12.31
EPS Growth
--------
Forward PE
--------
No. Analysts -----554
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 35.4M 32.1M 124.7M
Avg 31.6M 24.9M 60.6M
Low 27.7M 17.8M n/a

Revenue Growth

Revenue Growth 202520262027
High
24.1%
1.6%
401.5%
Avg
10.8%
-21.3%
143.6%
Low
-2.9%
-43.6%
-

EPS Forecast

EPS 20252026202720282029
High -6.60 -9.50 -12.67
Avg -6.42 -9.23 -12.31
Low -6.16 -8.87 -11.83

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.